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Abstract
Targeting of oncogenic Kras to the pancreatic Nestin-expressing embryonic progenitor cells and subsequently to the adult
acinar compartment and Nestin-expressing cells is sufficient for the development of low grade pancreatic intraepithelial
neoplasia (PanIN) between 2 and 4 months. The mice die around 6 month-old of unrelated causes, and it is therefore not
possible to assess whether the lesions will progress to carcinoma. We now report that two brief episodes of caerulein-
induced acute pancreatitis in 2 month-old mice causes rapid PanIN progression and pancreatic ductal adenocarcinoma
(PDAC) development by 4 months of age. These events occur with similar frequency as observed in animals where the
oncogene is targeted during embryogenesis to all pancreatic cell types. Thus, these data show that oncogenic Kras-driven
PanIN originating in a non-ductal compartment can rapidly progress to PDAC when subjected to a brief inflammatory insult.
Citation: Carrie `re C, Young AL, Gunn JR, Longnecker DS, Korc M (2011) Acute Pancreatitis Accelerates Initiation and Progression to Pancreatic Cancer in Mice
Expressing Oncogenic Kras in the Nestin Cell Lineage. PLoS ONE 6(11): e27725. doi:10.1371/journal.pone.0027725
Editor: Wafik S. El-Deiry, Penn State Hershey Cancer Institute, United States of America
Received June 7, 2011; Accepted October 23, 2011; Published November 28, 2011
Copyright:  2011 Carrie `re et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from: The National Cancer Institute: CA- R37-075059 to Murray Korc and CA-127095 to Catherine Carrie `re; The
Lustgarten Foundation for Pancreatic Cancer Research to Catherine Carrie `re. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Carriere@Dartmouth.edu
Introduction
Pancreatic ductal adenocarcinoma (PDAC) accounts for over
95% of all exocrine pancreatic malignancies and is the fourth
leading cause of cancer-related death in the United States, with a
mediansurvival of6 months[1]. Inthe last30years,patient survival
rates have not improved substantially, and PDAC remains
intractable in its late stages. Thus, there is an urgent need to
develop new approaches for early detection of PDAC as well as new
therapies targetingearly cancer stages. Mouse models of PDAC that
recapitulate human cancer have the potential to advance our
understanding of the early events in cancer development.
PDAC is now recognized to arise predominantly through
progression of pancreatic intraepithelial neoplasia (PanIN),
ranging from low- (PanIN-1A, -1B) to high-grades (PanIN-2, -3),
PanIN-3 representing carcinoma in situ and the immediate
precursor to ductal adenocarcinoma [2]. This histologic progres-
sion is correlated with the accumulation of genetic abnormalities of
which mutations leading to the constitutive activation of KRAS
are the earliest and most common (95%) [3]. The first relevant
mouse models of PDAC were generated by targeting a
conditionally mutated Kras allele (Kras
G12D) to early pancreatic
progenitors (using Pdx1 and Ptf1a promoters) and subsequently to
all pancreatic cell types [4,5]. These models recapitulated faithfully
the full spectrum of human PanIN progression and pancreatic
cancer development, demonstrating that oncogenic Kras expres-
sion is sufficient for PDAC initiation. To delineate the cells of
origin of PDAC, several models were subsequently developed
where mutated Kras was targeted to more restricted embryonic or
adult cell populations. We used a Nestin-Cre driver to target
Kras
G12D to acinar and Nestin-expressing cells (Nestin-Cre; LSL-
Kras
G12D or N/K mice) (Fig. 1A), whereas others targeted
oncogenic Kras to the acinar only or acinar/centroacinar cells
with different elastase-Cre and mist1-Cre drivers [6,7,8,9]. In all
these models, PDAC initiation and progression could be observed,
demonstrating that PDAC can have a non-ductal origin in mice.
Although a recent study suggested that PDAC could initiate in the
endocrine compartment, it has been shown that the promoter used
in this study could also target a small fraction of acinar cells
[10,11]. In all the models where oncogenic Kras was activated
during embryogenesis, low-grade PanINs developed, generally
progressing over 8–12 months to high-grade lesions and PDAC.
We were not able to observe progression to PDAC in N/K mice,
as they generally die around age 6 months from of central nervous
system complications.
Activation of Kras
G12D in the adult pancreas led to non-
progressing low-grade lesion formation [7,8,12]. However,
following induction of chronic pancreatitis, these animals devel-
oped high-grade lesions and progressed to PDAC [7]. These data
are consistent with epidemiologic studies showing that patients
suffering from chronic pancreatitis have a 16-fold increased risk of
developing pancreatic cancer [13]. While brief episodes of acute
pancreatitis (AP) lead to rapid PanIN progression and increased
frequency of PDAC in Pdx1-Cre; LSL-Kras
G12D mice [14,15,16],
it is unknown if it would also lead to PDAC in the Nestin-driven
mouse model. We now show that N/K mice, when subjected to
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27725two episodes of caerulein-induced AP, rapidly develop high-grade
PanINs that have the capacity to progress to PDAC. This study
confirms that acute pancreatic injury has the potential to
contribute to PDAC development in Kras-based mouse models
and support the hypothesis that PDAC can arise in the Nestin cell
lineage.
Results
Nestin progenitor cells do not give rise to ductal cells
We have previously shown that embryonic Nestin-expressing
pancreatic progenitors give rise to acinar cells and not to
endocrine or centroacinar cells, while a potential contribution to
ductal cells was not completely excluded [6]. To resolve this issue,
multiple lineage tracing experiments were done by breeding the
mouse line that expresses the Cre recombinase under the control
of Nestin regulatory elements [17] with the reporter mouse line
R26R. This last line carries the b-Galactosidase (LacZ) gene under
the control of the ubiquitous promoter R26 and a transcriptional
stop region surrounded by LoxP sites (LoxP-Stop-LoxP or LSL)
[18]. In the double transgenic mice, LacZ expression is activated
following Cre-mediated recombination in embryonic Nestin-
expressing cells (similar approach to the one described for Kras
in Fig. 1A). Subsequently, by genetic transmission, all cells derived
from the Nestin-expressing progenitors express LacZ. Sections
across the pancreata of Nestin-Cre/R26R animals at 2 months of
age were stained for LacZ activity. As observed before, the Nestin-
Cre transgene allowed for the targeting of ,70% of acinar cells
(Fig. 1B). LacZ staining was observed only in acinar structures,
never in the ductal, endocrine or centroacinar cells (Fig. 1B) and
co-immunofluorescence with the ductal marker cytokeratin 19
(CK19) confirmed this observation (Fig. 1C–E). These results
demonstrate that embryonic pancreatic Nestin-expressing progen-
itors do not give rise to ductal cells (Fig. 1F). Expression of LacZ
was also rarely observed in pancreatic non-parenchymal cell types
such as endothelial and mesenchymal cells (not shown).
Acute pancreatitis dramatically accelerates lesion
progression in N/K pancreata
Between 2 to 6 months, N/K mice developed low grade PanINs
in limited numbers (2–10 isolated lesions or small foci per section),
as well as limited areas of acinar to ductal metaplasia (ADM)
(Fig. 2A–B, G) similar to what is observed in Pdx1-Cre; LSL-
Kras
G12D (P/K) mice [4,14]. While with time P/K mice can
develop PDAC but at very low frequency, N/K mutant mice
rarely survived past 6 months due to severe neurological problems,
preventing us from following a possible progression to pancreatic
cancer.
We have previously shown that two episodes of acute
pancreatitis (AP) induced by caerulein accelerated PanIN
progression from low- to high-grade and increased PDAC
frequency in the P/K mouse model [14]. To test the possibility
that mutated Kras activation in the Nestin lineage could lead to
PDAC, a cohort of 17 2-month-old N/K mice were subjected to
caerulein treatment. Caerulein is a cholecystokinin (CCK) analog
that binds to and activates the CCK receptor [19,20]. While the
drug dosage we used is low compared to the ones used by other
groups [21,22], extensive loss of acinar cells was observed in wild
type mice at 24 and 48 hours following AP, concomitant with a
dramatic inflammatory infiltration and interstitial expansion
(Fig.S1) as described by others [21,22,23]. One week following
AP, nearly complete regeneration of the pancreas was observed at
the histological level, with rare residual inflammatory infiltrates
while proliferation levels remained high as shown by Ki67
expression in acinar cells (Fig.S1A–D). These results are consistent
with another published report [15]. To evaluate the possibility that
following pancreatic injury, Nestin expression could be detected in
different pancreatic cell types, short term lineage tracing
experiments were done. LacZ staining in Nestin-Cre/R26R
pancreata, 1 week post caerulein treatment, was observed only
in acinar structures and no staining was detected in endocrine,
centroacinar or ductal cells (not shown).
All 17 caerulein-treated N/K mice started getting sick when
they were about 4 month-old, 2 months post-treatment, and had
to be sacrificed. Six animals were lost without necropsy. By
contrast, only 3 out of 9 untreated N/K mice died and none of the
others were sacrificed due to sickness during this period. P/K mice
when subjected to AP did not have shorter life expectancy than
untreated mice at least over a period of 8 months (not shown).
These observations suggested that the decrease in overall survival
of N/K mice from 6 to 4 months was not directly related to
pancreatic insufficiency. Four month-old N/K pancreata exhib-
ited few PanIN-1A and -1B and rare ADM foci (less than 5% of
the section) (Fig. 2A, B and G). Two months post caerulein-
induced AP extensive pancreatic dysplasia was observed in N/K
pancreata characterized by a mix of low- and high-grade PanIN
and large ADM foci (Fig. 2C–F). The increase in lesion grade and
the extensive ADM were documented by morphometric analyses
that compared the presence and grade of lesions between sections
Figure 1. Targeting strategy with the Nestin-Cre transgene. (A)
Schematic of the conditional Kras
G12D allele. In the absence of the Cre
recombinase, only WT Kras is expressed; once Cre is expressed, the stop
region is excised and Kras
G12D becomes expressed. (B–E) In Nestin-Cre/
R26R mice, LacZ staining is observed only in acinar cells (B), and is
absent in ductal cells (arrowheads) and islets (I). (C) Overlay of LacZ
immunostaining (E) with CK19 (D) demonstrates that ductal cells are
not targeted. (F) Pdx1-Cre leads to the expression of Kras
G12D in all
pancreatic cell types while Nestin-Cre drives the expression of Kras
G12D
only in acinar cells. Scale bar: 20 mm.
doi:10.1371/journal.pone.0027725.g001
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untreated N/K pancreata exhibited low-grade lesions only and
less than 5% of the section presented ADM, most caerulein-treated
pancreata showed significant increases in PanIN-2 and -3
(P,0.0002) as well as extensive ADM covering 15 to 95% of the
pancreas (Fig. 2G). These findings are similar to those we observed
in a parallel cohort of P/K subjected at 2 month-old to caerulein-
induced AP (Fig.S2); P/K mice were sacrificed 6 months post
treatment (at age 8 months) which explains the higher rates of
high-grade lesions and PDAC/microinvasion both in untreated
and treated mice. As observed in N/K mice, all the caerulein-
treated P/K mice show extensive ADM covering 25–95% of the
sections (P,0.001) and dramatic progression to high-grade lesions
and PDAC (Fig.S2). In contrast, in all control animals (wild type or
carrying a single mutation, Nestin-Cre, Pdx1-Cre or LSL-
Kras
G12D only) treated with caerulein, the pancreata appeared
to be normal with occasionally residual traces of inflammation (not
shown).
Low-grade lesions in N/K pancreata showed a proliferation
index of 13%63% similar to what is observed in P/K mice [4].
The high-grade lesions observed after caerulein treatment
displayed as expected a high proliferation index (55%63%), but
interestingly low-grade lesions also showed a higher proliferation
index of 31%64% (Fig. 2H, S3A). Thus, the general increase in
proliferation observed in the pancreas immediately following AP
episodes [21] was maintained 2 months post injury but only in the
neoplastic lesions in the presence of an activated Kras allele.
As observed in human PDAC samples, PanINs expressed high
level of CK19, underscoring their epithelial nature, displayed
mucus accumulation as shown by Muc5a expression (Fig.S3B–C),
and were surrounded by collagen-rich stroma (Fig. S3F). The
lesions showed a reactivation of the early pancreatic progenitor
marker Pdx1 as well as the Notch signaling marker Hes1, both
known to be reactivated in early stages of PDAC (Fig.S3D–E).
ADM was demonstrated by the co-expression of acinar and ductal
markers in the same cells (Fig.S3G–I) as observed by others [24].
These data confirm that caerulein-induced AP does not affect the
nature of the lesions at the molecular level but accelerates their
progression to high grade.
It was shown recently that the inflammatory mediator Stat3 and
the interleukin IL6 were essential contributors to PanIN
progression and PDAC development at least in the early stages
of the disease and were essential components for the acute
response to caerulein-induced AP [16,25]. Immunohistochemical
analysis in N/K pancreata showed that phospho-Stat3 was still
highly expressed 2 months post AP (Fig. 3) while IL6 was not
detected (not shown). Phospho-Stat3 was shown previously to be
highly activated in PanINs immediately following AP episodes
[16,25]. However, two months later phospho-Stat3 did not appear
to be expressed in the lesions themselves but was abundantly
detected in the inflammatory cells, in ADM foci and in groups of
apparently normal acinar cells (Fig. 3A–D). Similarly, in untreated
N/K mice, phospho-Stat3 was rarely detected and only in cells
surrounding the PanINs (not shown).
Oncogenic Kras activation in the Nestin cell lineage leads
to PDAC development
In half the mice subjected to AP, areas of microinvasion can be
observed in the pancreata as shown by the loss of the basement
membrane in some PanIN-3 (Fig. 4A–B) and CK19 expression in
cells within the adjacent stroma (Fig. 4C). From a small group of 4
N/K animals treated with caerulein at later stages (4 month-old), 3
survived until age 6 months and of these, 2 displayed tumors
(diameter ,5 mm) visible at the gross anatomical level. Only one
tumor was available for histological analysis, displaying the
morphological characteristic of PDAC, and revealing local
invasion of the fat and fibrous tissues (Fig. 4D). Despite the fact
that the nuclei were enlarged and crowded, a glandular
Figure 2. Caerulein treatment leads to major PanIN lesion progression 2 months following caerulein treatment. (A–F) H&E staining of
4 months old N/K pancreata: (A–B) untreated pancreas displaying rare low-grade lesions (*), (B) inset from (A) shows a single PanIN-1A lesion; (C–F)
caerulein-treated pancreata show extensive dysplasia with a mix of low- (*) and high-grade (arrowhead) lesions (D, inset of C) and (E) as well as ADM
foci (marked by dotted line)(F). (G) Morphometric analyses show dramatic increases in the number of animals displaying high grade PanIN lesions and
areas of microinvasion in caerulein-treated pancreata. (H) Significant increases in proliferation are observed in caerulein treated pancreata (* P,0.05,
** P,0.01). Scale bar: 50 mm.
doi:10.1371/journal.pone.0027725.g002
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also observed (Fig. 4E–F). Large areas of the pancreas displayed
extensive ADM (not shown). As observed in human PDAC, the
tumors were highly proliferative as shown by Ki67 expression
(Fig. 4G) and surrounded by conspicuously reactive stroma
characterized by smooth muscle actin (SMA) expression
(Fig. 4H). While we also observed high levels of Cox2 in PanINs,
its expression was low in the cancer cells which is surprising as it is
known to be upregulated in human PDAC (Fig. 4I).
Nestin is expressed in human and mouse PanIN
Following AP, the pancreas undergoes intense proliferation and
regeneration, and increases in Nestin expression have been
observed by different groups [26,27]. It is unclear if this increase
occurs via an expansion of an already existing population of adult
Nestin-expressing cells or is due to a transient expression of Nestin
in dedifferentiating and proliferating acinar cells. We now show by
immunohistochemistry that Nestin is consistently expressed in
mouse PanIN from low to high-grade as well as in human PanINs
and PDAC (Fig. 5).
Discussion
We showed previously that N/K and the P/K mouse models
develop low grade PanINs with similar timing and efficiency
between 2 and 4 months of age [6]. These data suggested that
PDAC initiation occurred mainly in the Nestin cell lineage, which
consists in the pancreas of acinar cells and rare adult pancreatic
Nestin-expressing cells. Still, the limited survival of the N/K mice
past 6 months prevented us from pursuing the comparison to the
PDAC stage. In the present study, we show that two close episodes
of caerulein-induced AP in 2 month-old NK mice not only cause
rapid PanIN progression from low- to high-grade but also with low
frequency leads to PDAC. The progression efficiency appears
Figure 3. Stat3 activation is maintained 2 months post AP
mainly in inflammatory cells and ADM area. (A–D) IHC for
phospho-Stat3 in N/K pancreata 2 months post caerulein treatment. (A)
Low magnification picture of a representative area. Phospho-Stat3 is
rarely expressed in developing PanIN lesions but is observed in the cells
that display a normal ductal morphology (B, arrows); (it is mainly
expressed in inflammatory cells (C), in cells undergoing ADM (C, D,
arrows) as well as in morphologically normal acinar cells (D,
arrowheads). Scale bar: 20 mm.
doi:10.1371/journal.pone.0027725.g003
Figure 4. NK mice develop pancreatic ductal adenocarcinoma. High-grade lesions display microinvasion (A, arrowheads) and (B) as shown by
CK19 expression (adjacent section) in cells in the adjacent stroma (C); (D) Low magnification shows the local invasion of fat and fibrous tissues
(arrows). (E) Nuclei are enlarged, crowded and glandular morphology is maintained. (F) Low grade PanINs (stars) are observed in proximity with
adenocarcinoma (arrows). (G) Adenocarcinoma cells are highly proliferative as shown by Ki67 expression. They are surrounded by reactive stroma
characterized by SMA expression (H). Cox2 expression while high in the PanINs (arrows) is absent from the adenocarcinoma per se (arrowheads)(I).
Scale bar: 20 mm.
doi:10.1371/journal.pone.0027725.g004
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induced AP [14]. These data demonstrate that N/K mice are a
bona fide model of PDAC, and further support that the pancreatic
Nestin lineage is the cell lineage that is mainly responsive to Kras
mutation in the pancreas.
The targeting of oncogenic Kras to the acinar compartment,
using different acinar-specific promoters also leads to the
development in adult mouse of PanINs [8,9] and infrequent
invasive PDAC [7]. In N/K mice, Kras
G12D is activated in acinar
cells as well as in adult Nestin-expressing cells. These later cells
represent less than 0.1% of the total pancreas, appear integrated in
the acinar structure but do not display differentiation markers
(manuscript in preparation, CC and MK). At this stage, their
function remains unknown. It is important to note that the Nestin
regulatory elements used for these experiments target all Nestin-
expressing cells in the animal [17]. Cre expression can be traced
occasionally in endothelial and mesenchymal cells but there are no
data in the literature suggesting that pancreatic cancer could
initiate in non parenchymal cells. Thus taken together, these data
provide strong evidence for a non-ductal cell origin of PDAC at
least in the mouse.
Progression from PanIN to cancer is dramatically accelerated
when the mice are subjected to environmental insults such as
chronic pancreatitis [7,10]. These data correlate with human
epidemiological studies showing that chronic pancreatitis increases
the risk of developing PDAC [13]. Our data and others show that
caerulein-induced AP acts as cancer promoter in PDAC mouse
models [14,15,16], suggesting that AP, when occurring in an
individual whose pancreas harbors a Kras mutation, could
potentially increase PDAC risk.
By which mechanisms does AP affect cancer progression?
Recovery from AP in humans does not necessarily lead to
irreversible damage and may be associated with pancreatic
regeneration [28] as observed in the mouse. During the first 3
days following caerulein treatment, the mouse pancreas develop
tubular structures in place of acini [23], and lineage tracing
experiments using the elastase promoter suggest that part of these
tubular structures are derived from acinar cells that appear to
dedifferentiate, by going through a ductal-like metaplastic
intermediate state before entering proliferation [23,29]. New
acinar cells originate then essentially from preexisting acinar cells
[22,23,29] and have to undergo a secondary ductal to acinar
metaplasia (DAM), an essential step for pancreas regeneration
[15]. Interestingly, following AP, acinar cells that expressed
oncogenic Kras died or underwent ADM. Among the acinar
structures undergoing ADM, some appeared to give rise to PanIN,
at least during the short period in which the mice were analyzed
[15]. Pancreas regeneration also appeared to be stalled suggesting
that Kras
G12D-expressing cells that underwent ADM were not able
to undergo the reverse process DAM to generate new acinar cells
[15]. We observed extensive ADM/low-grade PanIN formation in
both P/K and N/K pancreata in the 2–6 months following AP
arguing again that large number of pancreatic cells respond to
oncogene activation. Still, only few higher grade lesions can be
detected. It suggests that while most acinar cells do respond to a
certain extent to oncogenic Kras following caerulein-induced AP
by undergoing ADM, they are not competent to progress to higher
grade lesions and PDAC.
Nestin expression is upregulated in different models of pancreas
regeneration and Nestin has been proposed as a transient marker
of acinar dedifferentiation [26,29]. It is also known as a stem cell
marker during both embryogenesis and adulthood in different
organs. One could then speculate that pancreatic adult Nestin-
expressing cells are in fact adult acinar progenitors and that
pancreas regeneration following AP occurs in part via the
expansion of these progenitors. As such, adult Nestin-expressing
cells would potentially be more competent for cancer initiation
and progression following AP-induced proliferation, as suggested
by the expression of Nestin in all grade lesions both in human and
in mice. More experiments will be required to evaluate these
possibilities.
Recent work showed that the inflammatory mediator Stat3 is
activated at all stages of pancreatic cancer from low-grade PanIN
to PDAC and is required for cancer progression [25,30]. AP
causes transient Stat3 activation in normal pancreas. In P/K mice,
caerulein-induced AP leads to a major upregulation of phospho-
Stat3 both in neoplastic lesions and the surrounding microenvi-
ronment in the 2–3 weeks following its induction. Indeed,
Figure 5. Nestin is expressed in human and mouse PanIN. (A–D) Human PanIN; mouse PanIN in NK (E–G) and PK (I–K). Overlays of CK19
(green), Nestin (red) and Hoescht (blue) show clear coexpression of Nestin with CK19 in the lesions (A, E, I). In contrast, in normal ducts, only CK19 is
expressed (arrows)(H, L). (D) On human tissue, the secondary antibody alone generates high background in the stroma but no expression in PanIN
(arrow). Scale bar: 20 mm.
doi:10.1371/journal.pone.0027725.g005
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accelerated neoplastic progression in P/K mice following AP [16].
In our model two months post AP, phospho-Stat3 was only rarely
detected in PanINs. In contrast, it was expressed mainly in the
surrounding inflammatory cells, and in ADM foci as well as in
small groups of histologically normal acinar cells. These
observations suggest that Stat3 activation could be involved in
metaplastic processes as the initiating steps in neoplastic
transformation. The fact that extensive areas of ADM are still
observed after 2 months also suggests that other events are
required for the ADM to progress to PanIN. Increased levels of
Kras
G12D activity could be an essential component for this
progression [31,32].
Recent studies showed that PDAC grows slowly over several
decades and metastasize only in ‘‘late’’ stages [33,34]. This
suggests that early detection and prevention could be the most
valuable approaches to confront this highly lethal cancer. Defining
the cell types in which cancer can initiate as well as understanding
the mechanisms by which environmental injuries can affect cancer
progression are both essential for these approaches.
Materials and Methods
All animal experiments were approved by the Institutional






generated by D.A. Tuveson and T. Jacks [35] and obtained from
MMHCC, NCI. The Nestin-Cre mice (B6.Cg-Tg(Nes-cre)1
Kln/J)
generated by R. Klein [17] were purchased from the Jackson
laboratory. Pdx1-Cre mice were a gift from G. Gu [35]. All
genotyping were done by PCR following the conditions of the
providers. Two episodes of acute pancreatitis were induced by a
series of seven hourly intraperitoneal injections of caerulein given
on 2 consecutive days, as described [14]. Caerulein (Sigma, St.
Louis MO) was diluted in PBS and injected at a dose of 50 mg/kg
of body weight. A second group of compound mutant and control
animals received injections of PBS only. All animals were fasted for
12 hours before the experiment.
Histology and immunohistochemistry
Mice were perfused with PBS then 10% formalin/PBS and the
pancreata dissected. For bGalactosidase staining, tissues were
transferred directly after perfusion into 30% sucrose at 4uC, and
24 hours later cryoembedded in OCT compound. For histology
and most immunostaining, pancreata were fixed overnight and
processed for paraffin embedding. Routine Hematoxylin and
Eosin (H&E) staining was performed using standard procedures.
For immunostaining, sections were deparaffinized, rehydrated and
antigens were retrieved if required using a 2100-Retriever and
antigen unmasking solution (Vector Laboratories). For cytokeratin
19 (CK19) immunostaining, Proteinase K antigen retrieval
procedure was used. Immunostaining procedures were as
described previously [5]. The antibodies and dilution used were:
TromaIII (CK19 antibody developed by Rolf Kemler and
obtained from Developmental Studies Hybridoma Bank, 1:10),
anti-bGalactosidase (rabbit, Cappel, 1:200), anti-Muc5a (Novo-
castra, 1:30), anti-Ki67 (mouse, Novocastra, 1:200), anti-Hes1 (a
gift from Dr. T. Sudo, Toray Inc., Kamakura, Japan; 1:400), anti-
Cox2 and anti-phospho-Stat3 (Tyr705) (both Cell Signaling 1:50),
anti-Pdx1 (Upstate1:5000), anti-aSMA (Abcam, 1:100), anti-
Nestin (Chemicon, AB5922 for human, MAB353 for mouse,
1:100), and anti-amylase (Calbiochem, 1:500).
Pictures were captured with a QImaging EXI Blue camera and
analyzed with ImagePro Plus 7.0. Fluorescence pictures were
captured using the Black and White settings and artificially colored
for analysis, except for Figure 5 in which pictures were taken using
the color settings; H&E and immunochemistry pictures were
captured using the Color settings. Photoshop was used to process
the pictures.
Supporting Information
Figure S1 Caerulein treatment leads to acute pancrea-
titis. H&E staining of pancreata untreated (A) and treated with
caerulein (B, C). (B) 48 hours following caerulein treatment (48 h
post C), the pancreas displays extensive ADM, exocrine atrophy
and inflammatory infiltration. (C) At 1 week post C, the pancreas
has regained its normal morphology but high levels of proliferation
are still observed as shown by Ki67 expression (D).
(TIF)
Figure S2 Morphometric analyses of P/K mice, 6
months post caerulein-induced AP. Dramatic increases in
the number of animals displaying extensive ADM, high grade
lesions and PDAC/microinvasion areas are observed when
compared with untreated animals.
(TIF)
Figure S3 PanIN characterization in NK mice. (A) Ki67
staining shows a clear increase in proliferation in low and high-
grade lesions. High-grade PanINs express CK19 (B), Muc5a (C).
Embryonic progenitors markers are reactivated (D, E). (F)
Masson’s trichrome blue staining shows the presence of collagen
around PanIN lesions. (G) Extensive ADM is observed as shown
by coexpression of CK19 (green, H) and amylase (red, I) in the
same cells (white arrowheads). Scale bar: 20 mm.
(TIF)
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